IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Casi Pharmaceuticals Inc (CASIF)

Q2 2026 vs Q3 2026

Comparing institutional holders between quarters

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile
West Paces Advisors Inc.
UNCHANGED
Shares100 from 100
Change0 (0%)
Value$11 (-$6)
Filed 2026-10-13
Status
West Paces Advisors Inc.
UNCHANGED10010000%$17$11-$62026-10-13
Showing 1 of 1 institutions